1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gene Therapy-based Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Viral Gene Delivery System 1.2.3 Non-viral Gene Delivery System 1.3 Market by Application 1.3.1 Global Gene Therapy-based Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Neurological Diseases 1.3.3 Cancer 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gene Therapy-based Drug Market Perspective (2016-2027) 2.2 Gene Therapy-based Drug Growth Trends by Regions 2.2.1 Gene Therapy-based Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Gene Therapy-based Drug Historic Market Share by Regions (2016-2021) 2.2.3 Gene Therapy-based Drug Forecasted Market Size by Regions (2022-2027) 2.3 Gene Therapy-based Drug Industry Dynamic 2.3.1 Gene Therapy-based Drug Market Trends 2.3.2 Gene Therapy-based Drug Market Drivers 2.3.3 Gene Therapy-based Drug Market Challenges 2.3.4 Gene Therapy-based Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gene Therapy-based Drug Players by Revenue 3.1.1 Global Top Gene Therapy-based Drug Players by Revenue (2016-2021) 3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2016-2021) 3.2 Global Gene Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gene Therapy-based Drug Revenue 3.4 Global Gene Therapy-based Drug Market Concentration Ratio 3.4.1 Global Gene Therapy-based Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy-based Drug Revenue in 2020 3.5 Gene Therapy-based Drug Key Players Head office and Area Served 3.6 Key Players Gene Therapy-based Drug Product Solution and Service 3.7 Date of Enter into Gene Therapy-based Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gene Therapy-based Drug Breakdown Data by Type 4.1 Global Gene Therapy-based Drug Historic Market Size by Type (2016-2021) 4.2 Global Gene Therapy-based Drug Forecasted Market Size by Type (2022-2027) 5 Gene Therapy-based Drug Breakdown Data by Application 5.1 Global Gene Therapy-based Drug Historic Market Size by Application (2016-2021) 5.2 Global Gene Therapy-based Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Gene Therapy-based Drug Market Size (2016-2027) 6.2 North America Gene Therapy-based Drug Market Size by Type 6.2.1 North America Gene Therapy-based Drug Market Size by Type (2016-2021) 6.2.2 North America Gene Therapy-based Drug Market Size by Type (2022-2027) 6.2.3 North America Gene Therapy-based Drug Market Size by Type (2016-2027) 6.3 North America Gene Therapy-based Drug Market Size by Application 6.3.1 North America Gene Therapy-based Drug Market Size by Application (2016-2021) 6.3.2 North America Gene Therapy-based Drug Market Size by Application (2022-2027) 6.3.3 North America Gene Therapy-based Drug Market Size by Application (2016-2027) 6.4 North America Gene Therapy-based Drug Market Size by Country 6.4.1 North America Gene Therapy-based Drug Market Size by Country (2016-2021) 6.4.2 North America Gene Therapy-based Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Gene Therapy-based Drug Market Size (2016-2027) 7.2 Europe Gene Therapy-based Drug Market Size by Type 7.2.1 Europe Gene Therapy-based Drug Market Size by Type (2016-2021) 7.2.2 Europe Gene Therapy-based Drug Market Size by Type (2022-2027) 7.2.3 Europe Gene Therapy-based Drug Market Size by Type (2016-2027) 7.3 Europe Gene Therapy-based Drug Market Size by Application 7.3.1 Europe Gene Therapy-based Drug Market Size by Application (2016-2021) 7.3.2 Europe Gene Therapy-based Drug Market Size by Application (2022-2027) 7.3.3 Europe Gene Therapy-based Drug Market Size by Application (2016-2027) 7.4 Europe Gene Therapy-based Drug Market Size by Country 7.4.1 Europe Gene Therapy-based Drug Market Size by Country (2016-2021) 7.4.2 Europe Gene Therapy-based Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Gene Therapy-based Drug Market Size (2016-2027) 8.2 Asia-Pacific Gene Therapy-based Drug Market Size by Type 8.2.1 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Gene Therapy-based Drug Market Size by Application 8.3.1 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Gene Therapy-based Drug Market Size by Region 8.4.1 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Gene Therapy-based Drug Market Size (2016-2027) 9.2 Latin America Gene Therapy-based Drug Market Size by Type 9.2.1 Latin America Gene Therapy-based Drug Market Size by Type (2016-2021) 9.2.2 Latin America Gene Therapy-based Drug Market Size by Type (2022-2027) 9.2.3 Latin America Gene Therapy-based Drug Market Size by Type (2016-2027) 9.3 Latin America Gene Therapy-based Drug Market Size by Application 9.3.1 Latin America Gene Therapy-based Drug Market Size by Application (2016-2021) 9.3.2 Latin America Gene Therapy-based Drug Market Size by Application (2022-2027) 9.3.3 Latin America Gene Therapy-based Drug Market Size by Application (2016-2027) 9.4 Latin America Gene Therapy-based Drug Market Size by Country 9.4.1 Latin America Gene Therapy-based Drug Market Size by Country (2016-2021) 9.4.2 Latin America Gene Therapy-based Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gene Therapy-based Drug Market Size (2016-2027) 10.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type 10.2.1 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application 10.3.1 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Gene Therapy-based Drug Market Size by Country 10.4.1 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Biogen 11.1.1 Biogen Company Details 11.1.2 Biogen Business Overview 11.1.3 Biogen Gene Therapy-based Drug Introduction 11.1.4 Biogen Revenue in Gene Therapy-based Drug Business (2016-2021) 11.1.5 Biogen Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Gene Therapy-based Drug Introduction 11.2.4 Novartis Revenue in Gene Therapy-based Drug Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Gilead Sciences 11.3.1 Gilead Sciences Company Details 11.3.2 Gilead Sciences Business Overview 11.3.3 Gilead Sciences Gene Therapy-based Drug Introduction 11.3.4 Gilead Sciences Revenue in Gene Therapy-based Drug Business (2016-2021) 11.3.5 Gilead Sciences Recent Development 11.4 Sarepta Therapeutics 11.4.1 Sarepta Therapeutics Company Details 11.4.2 Sarepta Therapeutics Business Overview 11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Introduction 11.4.4 Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) 11.4.5 Sarepta Therapeutics Recent Development 11.5 Alnylam Pharmaceuticals 11.5.1 Alnylam Pharmaceuticals Company Details 11.5.2 Alnylam Pharmaceuticals Business Overview 11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Introduction 11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2016-2021) 11.5.5 Alnylam Pharmaceuticals Recent Development 11.6 Amgen 11.6.1 Amgen Company Details 11.6.2 Amgen Business Overview 11.6.3 Amgen Gene Therapy-based Drug Introduction 11.6.4 Amgen Revenue in Gene Therapy-based Drug Business (2016-2021) 11.6.5 Amgen Recent Development 11.7 Spark Therapeutics 11.7.1 Spark Therapeutics Company Details 11.7.2 Spark Therapeutics Business Overview 11.7.3 Spark Therapeutics Gene Therapy-based Drug Introduction 11.7.4 Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) 11.7.5 Spark Therapeutics Recent Development 11.8 Akcea Therapeutics 11.8.1 Akcea Therapeutics Company Details 11.8.2 Akcea Therapeutics Business Overview 11.8.3 Akcea Therapeutics Gene Therapy-based Drug Introduction 11.8.4 Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) 11.8.5 Akcea Therapeutics Recent Development 11.9 bluebird bio 11.9.1 bluebird bio Company Details 11.9.2 bluebird bio Business Overview 11.9.3 bluebird bio Gene Therapy-based Drug Introduction 11.9.4 bluebird bio Revenue in Gene Therapy-based Drug Business (2016-2021) 11.9.5 bluebird bio Recent Development 11.10 Sunway Biotech 11.10.1 Sunway Biotech Company Details 11.10.2 Sunway Biotech Business Overview 11.10.3 Sunway Biotech Gene Therapy-based Drug Introduction 11.10.4 Sunway Biotech Revenue in Gene Therapy-based Drug Business (2016-2021) 11.10.5 Sunway Biotech Recent Development 11.11 SIBIONO 11.11.1 SIBIONO Company Details 11.11.2 SIBIONO Business Overview 11.11.3 SIBIONO Gene Therapy-based Drug Introduction 11.11.4 SIBIONO Revenue in Gene Therapy-based Drug Business (2016-2021) 11.11.5 SIBIONO Recent Development 11.12 AnGes 11.12.1 AnGes Company Details 11.12.2 AnGes Business Overview 11.12.3 AnGes Gene Therapy-based Drug Introduction 11.12.4 AnGes Revenue in Gene Therapy-based Drug Business (2016-2021) 11.12.5 AnGes Recent Development 11.13 Orchard Therapeutics 11.13.1 Orchard Therapeutics Company Details 11.13.2 Orchard Therapeutics Business Overview 11.13.3 Orchard Therapeutics Gene Therapy-based Drug Introduction 11.13.4 Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) 11.13.5 Orchard Therapeutics Recent Development 11.14 Human Stem Cells Institute 11.14.1 Human Stem Cells Institute Company Details 11.14.2 Human Stem Cells Institute Business Overview 11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Introduction 11.14.4 Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2016-2021) 11.14.5 Human Stem Cells Institute Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Gene Therapy-based Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Viral Gene Delivery System Table 3. Key Players of Non-viral Gene Delivery System Table 4. Global Gene Therapy-based Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Gene Therapy-based Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Gene Therapy-based Drug Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Gene Therapy-based Drug Market Share by Regions (2016-2021) Table 8. Global Gene Therapy-based Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Gene Therapy-based Drug Market Share by Regions (2022-2027) Table 10. Gene Therapy-based Drug Market Trends Table 11. Gene Therapy-based Drug Market Drivers Table 12. Gene Therapy-based Drug Market Challenges Table 13. Gene Therapy-based Drug Market Restraints Table 14. Global Gene Therapy-based Drug Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Gene Therapy-based Drug Market Share by Players (2016-2021) Table 16. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy-based Drug as of 2020) Table 17. Ranking of Global Top Gene Therapy-based Drug Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Gene Therapy-based Drug Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Gene Therapy-based Drug Product Solution and Service Table 21. Date of Enter into Gene Therapy-based Drug Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million) Table 24. Global Gene Therapy-based Drug Revenue Market Share by Type (2016-2021) Table 25. Global Gene Therapy-based Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Gene Therapy-based Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Gene Therapy-based Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Gene Therapy-based Drug Revenue Market Share by Application (2016-2021) Table 29. Global Gene Therapy-based Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Gene Therapy-based Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million) Table 32. North America Gene Therapy-based Drug Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Gene Therapy-based Drug Market Size by Application (2016-2021) (US$ Million) Table 34. North America Gene Therapy-based Drug Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Gene Therapy-based Drug Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Gene Therapy-based Drug Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Gene Therapy-based Drug Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Gene Therapy-based Drug Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Gene Therapy-based Drug Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Gene Therapy-based Drug Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Gene Therapy-based Drug Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Gene Therapy-based Drug Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Gene Therapy-based Drug Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Gene Therapy-based Drug Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Gene Therapy-based Drug Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Gene Therapy-based Drug Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Gene Therapy-based Drug Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Gene Therapy-based Drug Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Gene Therapy-based Drug Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Gene Therapy-based Drug Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Gene Therapy-based Drug Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Gene Therapy-based Drug Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Gene Therapy-based Drug Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Gene Therapy-based Drug Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Gene Therapy-based Drug Market Size by Country (2022-2027) & (US$ Million) Table 61. Biogen Company Details Table 62. Biogen Business Overview Table 63. Biogen Gene Therapy-based Drug Product Table 64. Biogen Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 65. Biogen Recent Development Table 66. Novartis Company Details Table 67. Novartis Business Overview Table 68. Novartis Gene Therapy-based Drug Product Table 69. Novartis Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 70. Novartis Recent Development Table 71. Gilead Sciences Company Details Table 72. Gilead Sciences Business Overview Table 73. Gilead Sciences Gene Therapy-based Drug Product Table 74. Gilead Sciences Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 75. Gilead Sciences Recent Development Table 76. Sarepta Therapeutics Company Details Table 77. Sarepta Therapeutics Business Overview Table 78. Sarepta Therapeutics Gene Therapy-based Drug Product Table 79. Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 80. Sarepta Therapeutics Recent Development Table 81. Alnylam Pharmaceuticals Company Details Table 82. Alnylam Pharmaceuticals Business Overview Table 83. Alnylam Pharmaceuticals Gene Therapy-based Drug Product Table 84. Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 85. Alnylam Pharmaceuticals Recent Development Table 86. Amgen Company Details Table 87. Amgen Business Overview Table 88. Amgen Gene Therapy-based Drug Product Table 89. Amgen Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 90. Amgen Recent Development Table 91. Spark Therapeutics Company Details Table 92. Spark Therapeutics Business Overview Table 93. Spark Therapeutics Gene Therapy-based Drug Product Table 94. Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 95. Spark Therapeutics Recent Development Table 96. Akcea Therapeutics Company Details Table 97. Akcea Therapeutics Business Overview Table 98. Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 99. Akcea Therapeutics Recent Development Table 100. bluebird bio Company Details Table 101. bluebird bio Business Overview Table 102. bluebird bio Gene Therapy-based Drug Product Table 103. bluebird bio Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 104. bluebird bio Recent Development Table 105. Sunway Biotech Company Details Table 106. Sunway Biotech Business Overview Table 107. Sunway Biotech Gene Therapy-based Drug Product Table 108. Sunway Biotech Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 109. Sunway Biotech Recent Development Table 110. SIBIONO Company Details Table 111. SIBIONO Business Overview Table 112. SIBIONO Gene Therapy-based Drug Product Table 113. SIBIONO Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 114. SIBIONO Recent Development Table 115. AnGes Company Details Table 116. AnGes Business Overview Table 117. AnGes Gene Therapy-based Drug Product Table 118. AnGes Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 119. AnGes Recent Development Table 120. Orchard Therapeutics Company Details Table 121. Orchard Therapeutics Business Overview Table 122. Orchard Therapeutics Gene Therapy-based Drug Product Table 123. Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 124. Orchard Therapeutics Recent Development Table 125. Human Stem Cells Institute Company Details Table 126. Human Stem Cells Institute Business Overview Table 127. Human Stem Cells Institute Gene Therapy-based Drug Product Table 128. Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2016-2021) & (US$ Million) Table 129. Human Stem Cells Institute Recent Development Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Global Gene Therapy-based Drug Market Share by Type: 2020 VS 2027 Figure 2. Viral Gene Delivery System Features Figure 3. Non-viral Gene Delivery System Features Figure 4. Global Gene Therapy-based Drug Market Share by Application: 2020 VS 2027 Figure 5. Neurological Diseases Case Studies Figure 6. Cancer Case Studies Figure 7. Other Case Studies Figure 8. Gene Therapy-based Drug Report Years Considered Figure 9. Global Gene Therapy-based Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Gene Therapy-based Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Gene Therapy-based Drug Market Share by Regions: 2020 VS 2027 Figure 12. Global Gene Therapy-based Drug Market Share by Regions (2022-2027) Figure 13. Global Gene Therapy-based Drug Market Share by Players in 2020 Figure 14. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy-based Drug as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy-based Drug Revenue in 2020 Figure 16. Global Gene Therapy-based Drug Revenue Market Share by Type (2016-2021) Figure 17. Global Gene Therapy-based Drug Revenue Market Share by Type (2022-2027) Figure 18. North America Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Gene Therapy-based Drug Market Share by Type (2016-2027) Figure 20. North America Gene Therapy-based Drug Market Share by Application (2016-2027) Figure 21. North America Gene Therapy-based Drug Market Share by Country (2016-2027) Figure 22. United States Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Gene Therapy-based Drug Market Share by Type (2016-2027) Figure 26. Europe Gene Therapy-based Drug Market Share by Application (2016-2027) Figure 27. Europe Gene Therapy-based Drug Market Share by Country (2016-2027) Figure 28. Germany Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Gene Therapy-based Drug Market Share by Type (2016-2027) Figure 36. Asia-Pacific Gene Therapy-based Drug Market Share by Application (2016-2027) Figure 37. Asia-Pacific Gene Therapy-based Drug Market Share by Region (2016-2027) Figure 38. China Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Gene Therapy-based Drug Market Share by Type (2016-2027) Figure 46. Latin America Gene Therapy-based Drug Market Share by Application (2016-2027) Figure 47. Latin America Gene Therapy-based Drug Market Share by Country (2016-2027) Figure 48. Mexico Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Gene Therapy-based Drug Market Share by Type (2016-2027) Figure 52. Middle East & Africa Gene Therapy-based Drug Market Share by Application (2016-2027) Figure 53. Middle East & Africa Gene Therapy-based Drug Market Share by Country (2016-2027) Figure 54. Turkey Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Gene Therapy-based Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Biogen Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 58. Novartis Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 59. Gilead Sciences Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 60. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 61. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 62. Amgen Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 63. Spark Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 64. Akcea Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 65. bluebird bio Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 66. Sunway Biotech Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 67. SIBIONO Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 68. AnGes Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 69. Orchard Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 70. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy-based Drug Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Biogen Novartis Gilead Sciences Sarepta Therapeutics Alnylam Pharmaceuticals Amgen Spark Therapeutics Akcea Therapeutics bluebird bio Sunway Biotech SIBIONO AnGes Orchard Therapeutics Human Stem Cells Institute